| Circulating and tumor-infiltrating myeloid-derived suppressor cells in patients with colorectal carcinoma B Zhang, Z Wang, L Wu, M Zhang, W Li, J Ding, J Zhu, H Wei, K Zhao PloS one 8 (2), e57114, 2013 | 330 | 2013 |
| Combined TIM-3 blockade and CD137 activation affords the long-term protection in a murine model of ovarian cancer Z Guo, D Cheng, Z Xia, M Luan, L Wu, G Wang, S Zhang Journal of translational medicine 11, 1-11, 2013 | 156 | 2013 |
| Co-delivery of tumor-derived exosomes with alpha-galactosylceramide on dendritic cell-based immunotherapy for glioblastoma H Liu, L Chen, J Liu, H Meng, R Zhang, L Ma, L Wu, S Yu, F Shi, Y Li, ... Cancer letters 411, 182-190, 2017 | 103 | 2017 |
| Ascites-derived IL-6 and IL-10 synergistically expand CD14+ HLA-DR-/low myeloid-derived suppressor cells in ovarian cancer patients L Wu, Z Deng, Y Peng, L Han, J Liu, L Wang, B Li, J Zhao, S Jiao, H Wei Oncotarget 8 (44), 76843, 2017 | 97 | 2017 |
| PTK2 promotes cancer stem cell traits in hepatocellular carcinoma by activating Wnt/β-catenin signaling Z Fan, J Duan, L Wang, S Xiao, L Li, X Yan, W Yao, L Wu, S Zhang, ... Cancer letters 450, 132-143, 2019 | 81 | 2019 |
| Dendritic cells loaded with tumor derived exosomes for cancer immunotherapy H Liu, L Chen, Y Peng, S Yu, J Liu, L Wu, L Zhang, Q Wu, X Chang, X Yu, ... Oncotarget 9 (2), 2887, 2018 | 81 | 2018 |
| Blocking the function of inflammatory cytokines and mediators by using IL-10 and TGF-β: A potential biological immunotherapy for intervertebral disc degeneration in a beagle model W Li, T Liu, L Wu, C Chen, Z Jia, X Bai, D Ruan International journal of molecular sciences 15 (10), 17270-17283, 2014 | 71 | 2014 |
| Regulatory T cells increase in breast cancer and in stage IV breast cancer Z Wang, B Yang, H Liu, Y Hu, J Yang, L Wu, Z Zhou, S Jiao Cancer Immunology, Immunotherapy 61, 911-916, 2012 | 68 | 2012 |
| Circulating and tumor‑infiltrating myeloid‑derived suppressor cells in cervical carcinoma patients L Wu, H Liu, H Guo, Q Wu, S Yu, Y Qin, G Wang, Q Wu, R Zhang, L Wang, ... Oncology letters 15 (6), 9507-9515, 2018 | 43 | 2018 |
| The PI3K inhibitor GDC-0941 enhances radiosensitization and reduces chemoresistance to temozolomide in GBM cell lines F Shi, H Guo, R Zhang, H Liu, L Wu, Q Wu, J Liu, T Liu, Q Zhang Neuroscience 346, 298-308, 2017 | 41 | 2017 |
| Prolonged overall survival in gastric cancer patients after adoptive immunotherapy GQ Zhang, H Zhao, JY Wu, JY Li, X Yan, G Wang, LL Wu, XG Zhang, ... World Journal of Gastroenterology: WJG 21 (9), 2777, 2015 | 38 | 2015 |
| PTK7-targeting CAR T-cells for the treatment of lung cancer and other malignancies Y Jie, G Liu, L Feng, Y Li, M E, L Wu, Y Li, G Rong, Y Li, H Wei, A Gu Frontiers in Immunology 12, 665970, 2021 | 32 | 2021 |
| The dual PI3K/mTOR inhibitor dactolisib elicits anti-tumor activity in vitro and in vivo F Shi, J Zhang, H Liu, L Wu, H Jiang, Q Wu, T Liu, M Lou, H Wu Oncotarget 9 (1), 706, 2018 | 30 | 2018 |
| Adoptive immunotherapy for non-small cell lung cancer by NK and cytotoxic T lymphocytes mixed effector cells: retrospective clinical observation G Zhang, H Zhao, J Wu, J Li, Y Xiang, G Wang, L Wu, S Jiao International Immunopharmacology 21 (2), 396-405, 2014 | 27 | 2014 |
| The ratio of IP10 to IL-8 in plasma reflects and predicts the response of patients with lung cancer to anti-PD-1 immunotherapy combined with chemotherapy L Wu, S Xie, L Wang, J Li, L Han, B Qin, G Zhang, Q Wu, W Gao, L Zhang, ... Frontiers in Immunology 12, 665147, 2021 | 19 | 2021 |
| New peptide MY1340 revert the inhibition effect of VEGF on dendritic cells differentiation and maturation via blocking VEGF-NRP-1 axis and inhibit tumor growth in vivo Z Mo, F Yu, S Han, S Yang, L Wu, P Li, S Jiao International Immunopharmacology 60, 132-140, 2018 | 18 | 2018 |
| Methylation of SLFN11 promotes gastric cancer growth and increases gastric cancer cell resistance to cisplatin Y Peng, L Wang, L Wu, L Zhang, G Nie, M Guo Journal of Cancer 10 (24), 6124, 2019 | 17 | 2019 |
| Multi-omics analysis uncovers tumor ecosystem dynamics during neoadjuvant toripalimab plus nab-paclitaxel and S-1 for esophageal squamous cell carcinoma: a single-center, open … G Zhang, J Yuan, C Pan, Q Xu, X Cui, J Zhang, M Liu, Z Song, L Wu, ... EBioMedicine 90, 2023 | 15 | 2023 |
| Dynamic testing of stimulative and suppressive biomarkers on peripheral blood cells at early stages of immunotherapy predicts response in advanced cancer patients W Du, S Hu, S Cai, Y Wang, L Wu, D Sun, S Jiao, Y Hu Discovery Medicine 25 (140), 277-290, 2018 | 9 | 2018 |
| A nomogram‑based immunoprofile predicts clinical outcomes for stage II and III human colorectal cancer L Wang, N Chang, L Wu, J Li, L Zhang, Y Chen, Z Zhou, J Hao, Q Wang, ... Molecular and Clinical Oncology 15 (6), 1-12, 2021 | 7 | 2021 |
